Loading clinical trials...
Loading clinical trials...
Phase I Study of Dose Escalation Using Image-guided Radiotherapy to Deliver a Stereotactic Radiosurgical Boost After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer
Conditions
Interventions
Capecitabine (Xeloda)
[18-F] Fluorodeoxyglucose (FDG)
+2 more
Locations
1
United States
Stanford University School of Medicine
Stanford, California, United States
Start Date
June 1, 2006
Primary Completion Date
March 1, 2009
Completion Date
March 1, 2009
Last Updated
July 16, 2012
NCT04704661
NCT05039801
NCT05691465
NCT06696768
NCT05198830
NCT04657068
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions